Cresco Labs (CRLBF) EBIT (2020 - 2026)

Cresco Labs' EBIT history runs 7 years deep, the most recent figure standing at $11.2 million for Q1 2026.

• Quarterly EBIT fell 17.78% year-over-year to $11.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$30.4 million (down 133.15% YoY) and the FY2025 annual result came in at -$28.0 million, down 126.08% from the prior year.
• EBIT was $11.2 million for Q1 2026 at Cresco Labs, up from -$75.5 million in the prior quarter.
• Across five years, EBIT topped out at $32.4 million in Q2 2024 and bottomed at -$143.5 million in Q4 2022.
• A 5-year average of -$4.8 million and a median of $16.2 million in 2022 frame the typical range for EBIT.
• Annual changes were most pronounced in 2022 — EBIT plunged 1022.28% — and 2024, when it surged 713.25%.
• Cresco Labs' EBIT stood at -$143.5 million in 2022, then jumped by 118.89% to $27.1 million in 2023, then declined by 28.39% to $19.4 million in 2024, then tumbled by 489.29% to -$75.5 million in 2025, then jumped by 114.79% to $11.2 million in 2026.
• Business Quant data shows CRLBF's EBIT at $11.2 million in Q1 2026, -$75.5 million in Q4 2025, and $17.8 million in Q3 2025.